Enzymatic Acrolein Production System and Its Impact on Human Cells.


Journal

Chemical research in toxicology
ISSN: 1520-5010
Titre abrégé: Chem Res Toxicol
Pays: United States
ID NLM: 8807448

Informations de publication

Date de publication:
19 Aug 2024
Historique:
medline: 19 8 2024
pubmed: 19 8 2024
entrez: 19 8 2024
Statut: ppublish

Résumé

Acrolein is an environmental toxicant and is also generated by microbial metabolism in the intestinal tract. Aqueous acrolein rapidly dissipates from standard human cell culture media with nondetectable levels after 8 h, hindering cell-based studies to understand its biological impacts. Thus, we developed an extracellular acrolein biosynthesis system to continuously produce acrolein compatible with human cell culture conditions. The approach uses spermine as a precursor, amine oxidase found in fetal calf serum, and catalase to remove the hydrogen peroxide byproduct. We confirmed amine oxidase activity of calf serum using a colorimetric assay and further tested the requirement for catalase in the system to mitigate hydrogen peroxide-induced cytotoxicity. We calibrated responses of human colon cells to this enzymatic acrolein production system by comparing transcriptional responses, DNA adduct formation and cytotoxicity responses to either this system or pure acrolein exposures in a human colon cell line. Several genes related to oxidative stress including HMOX1, and the colorectal cancer-related gene SEMA4A were upregulated similarly between the enzymatic acrolein production system or pure acrolein. The acrolein-DNA adduct γ-OH-Acr-dG increased in a dose-dependent manner with spermine in the enzymatic acrolein production system, producing a maximum of 1065 adducts per 10

Identifiants

pubmed: 39155646
doi: 10.1021/acs.chemrestox.4c00119
doi:

Substances chimiques

Acrolein 7864XYD3JJ
Hydrogen Peroxide BBX060AN9V
DNA Adducts 0
Catalase EC 1.11.1.6
Spermine 2FZ7Y3VOQX

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1374-1381

Auteurs

Katherine A Hurley (KA)

Department of Health Sciences and Technology, ETH Zürich, Zurich 8092, Switzerland.

Jacob Folz (J)

Department of Health Sciences and Technology, ETH Zürich, Zurich 8092, Switzerland.

Jasmin Zgraggen (J)

Department of Health Sciences and Technology, ETH Zürich, Zurich 8092, Switzerland.

Tania N Cruz (TN)

Department of Health Sciences and Technology, ETH Zürich, Zurich 8092, Switzerland.

Sabine Diedrich (S)

Department of Health Sciences and Technology, ETH Zürich, Zurich 8092, Switzerland.

Shana J Sturla (SJ)

Department of Health Sciences and Technology, ETH Zürich, Zurich 8092, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH